INC Research Plans to Acquire Late Stage Division of MDS for $50M

Tuesday, June 2, 2009 07:00 AM

Raleigh, N.C.-based contract research organization (CRO) INC Research entered into an agreement to acquire the phase II through IV operations of MDS Pharma Services, the clinical development division of MDS, for $50 million.

The deal is expected to close by the end of July, according to INC CEO James Ogle, and will complement INC's existing late-stage services and global footprint. As a result of the acquisition, INC Research will gain a stronghold in several countries where it previously had little to no presence, including China, Singapore, Malaysia, Peru, Argentina, Chile, Mexico, Brazil and South Africa, Ogle said.

As part of the acquisition deal, INC will take on all of MDS' existing late-stage employees and related facilities (both owned and leased) as well as approximately 100 active trials.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs